Microban International announces new range of antiviral technologies

<p style="text-align: center;"><img src="/ueditor/php/upload/image/20211111/1636616587124680.png" title="1636616587124680.png" alt="9.png"/></p><p>Microban International announced a new range of antiviral technologies that are proven to reduce viral loading on products and surfaces.</p><p><br/></p><p>Microban&nbsp;technology can be incorporated into various materials during manufacturing, becoming part of the product’s structure to provide inherent and enduring protection from microbes.</p><p><br/></p><p>Recent data demonstrates that new antiviral technologies from Microban conform to both ISO 18184 – which assesses the antiviral performance of treated textile products, such as woven and knitted fabrics, fibres, yarns, and braids – and ISO 21702, which measures activity in treated plastics and other non-porous surfaces.</p><p><br/></p><p>Testing was performed to evaluate the efficacy of each product type against many viruses, including bacteriophage Phi6, an important surrogate virus for SARS-CoV-2. The results showed that articles treated with these technologies can now benefit from reduced viral loading by up to 99 per cent.</p><p><br/></p><p>Antiviral technologies from Microban inhibit the viruses’ ability to remain viable on surfaces. The modes of action vary, disrupting the structure of either the outer protein coat – to prevent viruses from recognizing or binding to host cells – or nucleic acid payload, to prevent viral replication.</p><p><br/></p><p>“We are excited with the latest results confirming the antiviral activity of our new technologies. Assessing antiviral efficacy in treated products to a standard that meets the complex regulatory landscape is an arduous process, but we have been confident throughout that our innovative solutions&nbsp;conformed to the rigorous ISO standards,” said Michael Ruby, President, Microban International. “Our world-class research team and global in-house regulatory department worked diligently to ensure that the technology is recognised as effective and compliant across various markets, to support partners with their&nbsp;claims and give customers even greater confidence in products protected with Microban antiviral technology.”</p><p><br/></p>